Atlas Trials

Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)

Clinical trial NCT02633956 · COMPLETED

Trial details

NCT number
NCT02633956
Sponsor
Intercept Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nonalcoholic Steatohepatitis
Start date
2015-12-04
Primary completion
2017-03-21
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.